Key result
High serum uric acid linked to ~38% greater risk of proangiogenic progenitor cell depletion in CHF.
Why the study?
Is high serum uric acid associated with the depletion of proangiogenic mononuclear progenitor cells in patients with ischemic chronic heart failure?
Observational (n=126)
Yes
Is high serum uric acid associated with the depletion of proangiogenic mononuclear progenitor cells in patients with ischemic chronic heart failure?
Mild elevation of serum uric acid (>31.5 mmol/l) is associated with the depletion of proangiogenic mononuclear progenitor cells in patients with ischemic chronic heart failure, suggesting its potential as a prognostic biomarker.
Answers are grounded in this paper and cite their sources.
May support uric acid monitoring as a biomarker in ischemic HF; leaves open whether it causally drives progenitor depletion or improves outcomes.
Objective: Serum uric acid (UA) is considered as a marker of natural progression of chronic heart failure (CHF). Progression of CHF associates with declining of circulating mononuclear progenitor cells (MPCs) in the blood. The objective of this study was to evaluate the interrelationship between SUA concentrations and proangiogenic MPCs in ischemic CHF patients. Methods: The study was structured retrospectively after determining the coronary artery disease (CAD) by contrast-enhanced spiral computed tomography angiography in 126 subjects (54 male), aged 48 to 62 years, with CHF. Serum UA level was measured by enzymatic method and N-terminal proBNP (NT-pro-BNP) level was examined by immunoelectrochemiluminesence method. All biomarkers were measured at baseline. Results: Concentrations of SUA were distributed by quartiles (Me; IQR): QI=20.11 (19.06; 22.33) mmol/l; QII=27.53 (23.2; 31.10) mmol/l; QIII=35.80 (32.0; 39.0) mmol/l; and QIV=44.9 (40.00; 49.60) mmol/l. Cox proportional adjusted Odds Ratios analyses for CD14+CD309+ and CD14+CD309+Tie2+ MPCs by SUA Quartiles (Q) has showed that high Q (Q3 and Q4) of SUA versus low Q (Q1 and Q2) associated with increased risk of depletion of both CD14+CD309+ and CD14+CD309+Tie2+ MPCs. The ROC analysis has been showed that there was the cut-off point for the SUA level with the best prognostic potential on the risk of decreasing MPCs in both models equal 31.5 mmol/l. Conclusion: Circulated level of proangiogenic MPCs is declined progressively depended on quartiles of serum UA level in CHF subjects. We suggest that mild elevation of serum UA might be considered as a predictor of low proangiogenic MPCs in CHF patients.
No takes yet. Share an insight, caveat, or question.
Berezin et al. (2014) conducted an observational in Chronic heart failure (n=126). High serum uric acid (Quartile 4: 40.0-49.6 mmol/L) vs. Low serum uric acid (Quartile 1: 19.1-22.3 mmol/L) was evaluated on Depletion of CD14+CD309+Tie2+ mononuclear progenitor cells (OR 1.38, 95% CI 1.20-1.55, p=0.001). High serum uric acid levels were associated with an increased risk of depletion of proangiogenic CD14+CD309+Tie2+ mononuclear progenitor cells in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: